Dipentum Capsule, Gelatin Coated
Product Images NDC 0037-6860

2 FDA label images from Viatris Specialty Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Dipentum (NDC 0037-6860). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Viatris Specialty Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Olsalazine Sodium Structural Formula (Export 00)

Olsalazine Sodium Structural Formula (Export 00)
Chemical structure of olsalazine sodium, the active ingredient in Dipentum 250 mg capsules, showing the molecular arrangement of its sodium, hydroxyl, and carboxylate groups.*
FDA Label Image

Dipentum (olsalazine Sodium) 250 mg Bottle Label (Image 02)

Dipentum (olsalazine Sodium) 250 mg Bottle Label (Image 02)
Chemical structure of olsalazine sodium, the active ingredient in Dipentum 250 mg capsules. The structure features two benzene rings connected by an azo (N=N) group, with hydroxyl and carboxylate sodium groups attached to the rings.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.